GABRA6 rs6807402: Role in Stress and Autonomic Reactivity
The rs6807402 variant is a single-nucleotide polymorphism located within the GABRA6 gene on chromosome 5. This gene encodes a subunit of the major inhibitory GABA-A receptor complex in the central nervous system. Scientific research links this genetic marker to individual differences in autonomic reactivity and physiological stress responses, though overall clinical evidence remains limited.
What each genotype means
Attenuated physiological stress response
Carrying two copies of the C allele has been linked in preliminary laboratory stress models to a more dampened hypothalamic-pituitary-adrenal (HPA) axis and cardiovascular response during acute psychological stress, characterized by lower cortisol, ACTH, and blood pressure reactivity compared to T allele carriers. However, available scientific evidence remains limited, and larger population-level and clinical studies are needed to confirm these neuroendocrine associations. These statistical findings reflect modest physiological trends and do not represent a diagnosis or medical prediction.
Found in approximately 10% to 15% of European populations and roughly 20% of East Asian populations based on gnomAD allele frequencies.
Typical autonomic stress reactivity
Carrying one copy of the T allele and one copy of the C allele is associated with standard physiological reactivity during acute psychological stress, showing higher autonomic and cortisol responses than the homozygous CC genotype in experimental stress paradigms. Emerging research suggests these subtle variations may also interact with specific environmental stressors to influence mood regulation, though overall clinical evidence remains preliminary. This genotype describes population-level neurochemical tendencies and is not diagnostic of any stress or anxiety condition.
Carried by approximately 45% to 50% of people across most global populations, including European and East Asian cohorts.
Heightened autonomic stress reactivity
Individuals with two copies of the T allele have demonstrated significantly higher adrenocorticotropic hormone (ACTH), cortisol, and blood pressure elevations during standardized laboratory stress tasks compared to homozygous CC carriers. The literature also notes preliminary associations with specific personality traits and varying anxiety responses under specific life stressors, although evidence remains limited and exploratory. These findings indicate slight differences in physiological stress processing rather than a clinical disorder.
Present in roughly 40% to 45% of individuals of European ancestry and approximately 30% of East Asian populations.
Genomic Context and the GABRA6 Gene
The single-nucleotide polymorphism rs6807402 is situated on chromosome 5 within the GABRA6 gene. This gene provides instructions for building the alpha-6 subunit of the gamma-aminobutyric acid type A (GABA-A) receptor, as documented in NCBI Gene ([NCBI Gene Entry for GABRA6](https://www.ncbi.nlm.nih.gov/gene/2559)). GABA-A receptors are ligand-gated chloride ion channels that mediate the vast majority of fast inhibitory neurotransmission throughout the human brain. When activated by GABA, these channels open to allow chloride ions into neurons, dampening electrical excitability and helping regulate neural networks. The alpha-6 subunit is characteristically expressed in specialized brain regions, notably the cerebellum, and plays a role in tonic inhibitory signaling. Variations like rs6807402 fall within regulatory non-coding sequences that may influence how the gene is transcribed or fine-tuned across neural circuits.
Biological Mechanisms and Stress Reactivity
Exposure to psychological or environmental stress triggers the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic adrenomedullary system, raising cortisol and blood pressure. As reviewed in neurobiology publications, including research indexed on PubMed ([GABRA6 Gene Polymorphism and an Attenuated Stress Response](https://pubmed.ncbi.nlm.nih.gov/15197399)), inhibitory GABAergic signaling is vital for dampening these autonomic cascades. When central GABAergic tone is optimal, the brain can restrain excessive activation of stress pathways after a challenge. Genetic changes in GABA-A receptor subunits, such as variations in GABRA6, have been evaluated for their potential to alter post-synaptic inhibitory tone. This altered tone may change how acutely an individual reacts to psychosocial challenges, modulating blood pressure changes, heart rate responses, and subjective stress perception.
Current State of the Evidence
Scientific evidence connecting rs6807402 directly to distinct behavioral or clinical outcomes is currently classified as limited. Early candidate gene studies and psychophysiological laboratory experiments have observed small, statistical associations between GABRA6 variations and autonomic stress measurements, such as blood pressure changes during mental stressors. However, modern genome-wide association studies (GWAS) often show that complex psychological traits, mood disorders, and stress reactivity involve hundreds or thousands of genetic variants acting together, as explored in articles on [The Role of GABA-A Versus CB1 Receptor Gene Variants](https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2019.00138/full). Candidate variant findings for rs6807402 have not yet reached universal replication in large, diverse cohorts, meaning observed differences should be interpreted with caution.
Population Prevalence and Allele Distribution
The variant rs6807402 is common across global populations, meaning both alternative alleles are widely represented. Data aggregated in reference resources such as the Genome Aggregation Database ([gnomAD Browser](https://gnomad.broadinstitute.org/)) indicate noticeable differences in allele distributions between major continental ancestries. Specifically, the minor allele frequency is estimated at approximately 0.45 among East Asian populations and around 0.35 among European cohorts. Because both alleles are distributed widely across the world, neither allele represents a rare mutation or a pathological defect. Instead, rs6807402 represents normal human genetic diversity within the GABAergic receptor family.
Interpreting Your Genetic Data
Discovering your rs6807402 genotype does not provide a medical diagnosis or predict how you will personally cope with stressful life circumstances. Stress reactivity is an intricate physiological process influenced predominantly by lifestyle, social support, physical health, sleep quality, and personal history, rather than any individual DNA marker. This polymorphism is not used by clinical geneticists to guide therapy or screen for anxiety disorders. Furthermore, because GABA-A receptors are targeted by pharmaceutical agents such as benzodiazepines, individuals should never alter their medications or doses based on genetic testing; any medical or pharmacological adjustments should always be discussed directly with a qualified healthcare provider or pharmacist.
How common is this variant?
The rs6807402 variant is common worldwide, with the minor allele frequency reaching approximately 0.45 in East Asian populations and about 0.35 in European populations according to gnomAD reference datasets.
Frequently asked questions
Does having a specific rs6807402 genotype mean I will develop anxiety?
No. The rs6807402 variant is not a diagnostic marker for anxiety disorders, depression, or any other mental health condition. While research shows small statistical differences in how the autonomic nervous system responds to stress in laboratory settings, complex psychological traits depend on many genes, life experiences, and environmental factors.
What role does the GABRA6 gene play in the human body?
The GABRA6 gene encodes the alpha-6 subunit of the GABA-A receptor, which responds to gamma-aminobutyric acid, the primary inhibitory neurotransmitter in the brain. These receptors form chloride ion channels that quiet neuronal firing, playing an essential role in balancing brain communication and managing the physiological stress response.
Should I change how I take anxiety or sleep medications based on this variant?
No. You should never adjust prescription medications, such as GABA-targeting drugs or sedatives, based on commercial genetic test results. There are no clinical pharmacogenetic guidelines recommending dosing changes for rs6807402; any medication decisions must be made in consultation with your doctor or pharmacist.
How reliable is the scientific evidence linking rs6807402 to stress reactivity?
The evidence connecting rs6807402 directly to stress reactivity is limited and largely derived from small candidate gene studies. Modern genomic research demonstrates that autonomic responses are influenced by hundreds of genetic loci and environmental variables, so findings for single variants must be interpreted with caution.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6807402?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29